There are 2949 resources available
Q&A and live discussion
Presenter: Rosa Giuliani
Session: Proffered Paper - Public Policy
Resources:
Webcast
Invited Discussant LBA51, LBA52 and LBA53
Presenter: Roy Herbst
Session: Proffered Paper - NSCLC metastatic 2
Resources:
Slides
Webcast
Q&A live discussion
Presenter: Roy S. Herbst
Session: Proffered Paper - NSCLC metastatic 2
Resources:
Webcast
Invited Discussant LBA54 and LBA55
Presenter: Adrian Sacher
Session: Proffered Paper - NSCLC metastatic 2
Resources:
Slides
Webcast
Q&A live discussion
Presenter: Roy S. Herbst
Session: Proffered Paper - NSCLC metastatic 2
Resources:
Webcast
Q&A and live discussion
Presenter: Silke Gillessen
Session: Proffered Paper - GU, prostate
Resources:
Webcast
CN10 - Cancer nursing education and recognition in Europe: A survey by the European Oncology Nursing Society
Presenter: Patrick Crombez
Session: EONS13: Quality and safety of cancer nursing
Resources:
Abstract
Slides
Webcast
CN21 - Patient and occupational safety in Europe: A survey by the European Oncology Nursing Society
Presenter: Helena Ullgren
Session: EONS13: Quality and safety of cancer nursing
Resources:
Abstract
Slides
Webcast
CN9 - The European Cancer Nursing Index 2020: A tool for mapping cancer nursing status across Europe
Presenter: Lena Sharp
Session: EONS13: Quality and safety of cancer nursing
Resources:
Abstract
Slides
Webcast
LBA31 - Primary results from IMagyn050/GOG 3015/ENGOT-OV39, a double-blind placebo (pbo)-controlled randomised phase III trial of bevacizumab (bev)-containing therapy +/- atezolizumab (atezo) for newly diagnosed stage III/IV ovarian cancer (OC)
Presenter: Kathleen Moore
Session: Proffered Paper - Gynaecological cancers 2
Resources:
Abstract
Slides
Webcast